E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/3/2008 in the Prospect News Special Situations Daily.

Kensey Nash investor Parche cuts stake to 6.2%

By Lisa Kerner

Charlotte, N.C., Dec. 3 - Investors led by Parche, LLC cut their stake in Kensey Nash Corp. to 6.2%, from 7.7%, with the sale of 150,500 shares.

The shares were sold between Nov. 24 and Dec. 3 at prices from $16.904 to $18.4271 each, according to a schedule 13D/A filed with the Securities and Exchange Commission.

In a prior SEC filing, Parche reported the sale of 131,300 Kensey Nash shares between Oct. 30 and Nov. 14 at prices from $24.9334 to $28.8352 each.

Parche and its affiliates beneficially own 722,645 shares of the Exton, Pa., medical technology company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.